MA09-hRPE cells: Phase I/II start

FDA lifted a clinical hold on an IND for an open-label, U.S. Phase I/II trial evaluating MA09-hRPE cells in 12 patients following sub-retinal transplantation. Advanced Cell plans to begin the trial by...